Regents of the University of California’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,126
Closed -$354K 32
2020
Q2
$354K Hold
12,126
0.05% 28
2020
Q1
$317K Buy
+12,126
New +$370K 0.05% 26

Other funds holding HCAT

Regents of the University of California's HCAT Position: Q3 2020 in Review

Regents of the University of California sold out of Health Catalyst (HCAT) in Q3 2020, closing a stake of 12,126 shares — an estimated $354K sold.

Regents of the University of California first reported a position in HCAT in Q1 2020 and held it in 2 quarters. The position peaked at $354K in Q2 2020. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.

  • Regents of the University of California reported no remaining Health Catalyst position as of Q3 2020 after selling out during the quarter.
  • Regents of the University of California sold 12,126 Health Catalyst shares in Q3 2020, an estimated $354K.
  • Regents of the University of California first reported a position in Health Catalyst in Q1 2020 and held it in 2 quarters.
  • Regents of the University of California's Health Catalyst position peaked at $354K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.

Based on Regents of the University of California's 13F filing for Q3 2020, filed 21 Oct 2020.